CH655443B - - Google Patents

Info

Publication number
CH655443B
CH655443B CH110383A CH110383A CH655443B CH 655443 B CH655443 B CH 655443B CH 110383 A CH110383 A CH 110383A CH 110383 A CH110383 A CH 110383A CH 655443 B CH655443 B CH 655443B
Authority
CH
Switzerland
Application number
CH110383A
Other languages
German (de)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CH655443B publication Critical patent/CH655443B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH110383A 1981-06-23 1982-06-23 CH655443B (US06515009-20030204-C00004.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,465 US4455317A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (1)

Publication Number Publication Date
CH655443B true CH655443B (US06515009-20030204-C00004.png) 1986-04-30

Family

ID=23056760

Family Applications (1)

Application Number Title Priority Date Filing Date
CH110383A CH655443B (US06515009-20030204-C00004.png) 1981-06-23 1982-06-23

Country Status (18)

Country Link
US (1) US4455317A (US06515009-20030204-C00004.png)
EP (1) EP0081581B1 (US06515009-20030204-C00004.png)
JP (1) JPS58500995A (US06515009-20030204-C00004.png)
AU (1) AU558475B2 (US06515009-20030204-C00004.png)
CA (1) CA1176987A (US06515009-20030204-C00004.png)
CH (1) CH655443B (US06515009-20030204-C00004.png)
DE (1) DE3248837T1 (US06515009-20030204-C00004.png)
EG (1) EG16713A (US06515009-20030204-C00004.png)
ES (4) ES8405358A1 (US06515009-20030204-C00004.png)
GB (1) GB2112786B (US06515009-20030204-C00004.png)
GR (1) GR76842B (US06515009-20030204-C00004.png)
IL (1) IL66071A (US06515009-20030204-C00004.png)
IT (1) IT1156373B (US06515009-20030204-C00004.png)
NL (1) NL8220253A (US06515009-20030204-C00004.png)
NZ (1) NZ200973A (US06515009-20030204-C00004.png)
PH (1) PH18764A (US06515009-20030204-C00004.png)
WO (1) WO1983000015A1 (US06515009-20030204-C00004.png)
ZA (1) ZA824341B (US06515009-20030204-C00004.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4966914A (en) * 1988-12-15 1990-10-30 E. I. Du Pont De Nemours And Company Oculoselective beta-blockers as antiglaucoma agents
US4897417A (en) * 1988-12-15 1990-01-30 E. I. Du Pont De Nemours & Co. Prodrugs of 3,4-hydroxy benzoyloxypropanolamines
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
WO1997013744A1 (en) * 1995-10-10 1997-04-17 The University Of Melbourne 3-amino-propoxyphenyl derivatives (i)
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
US20070254950A1 (en) * 2004-05-25 2007-11-01 Othera Pharmaceuticals, Inc. Oculoselective Drugs and Prodrugs

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868460A (en) * 1967-02-06 1975-02-25 Boehringer Sohn Ingelheim Therapeutic compositions and method
US3740444A (en) * 1968-01-25 1973-06-19 Boehringer Sohn Ingelheim Therapeutic compositions and method
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
JPS49247A (US06515009-20030204-C00004.png) * 1972-04-17 1974-01-05
US3839584A (en) * 1972-08-31 1974-10-01 Interx Research Corp Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
FR2208653A2 (en) * 1972-12-06 1974-06-28 Orsymonde Cardiac antiarrhythmic phloroglucinol ethers - of hydroxy alkylaminoalkanoic acids
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3825583A (en) * 1973-04-26 1974-07-23 Interx Research Corp Ester of 3-hydroxy-alpha-((methylamino)methyl)benzyl alcohol
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
EP0003664B1 (en) * 1978-02-08 1982-02-17 Imperial Chemical Industries Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
EP0053434B1 (en) * 1980-11-28 1986-08-27 American Hospital Supply Corporation Compounds and method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
US4455317A (en) 1984-06-19
NZ200973A (en) 1986-04-11
IT1156373B (it) 1987-02-04
EG16713A (en) 1990-10-30
AU558475B2 (en) 1987-01-29
AU8737082A (en) 1983-01-18
EP0081581A1 (en) 1983-06-22
GB8303062D0 (en) 1983-03-09
PH18764A (en) 1985-09-20
JPS58500995A (ja) 1983-06-23
GB2112786B (en) 1986-02-19
GB2112786A (en) 1983-07-27
ES530209A0 (es) 1985-09-01
IT8267794A0 (it) 1982-06-22
ES8507467A1 (es) 1985-09-01
CA1176987A (en) 1984-10-30
DE3248837T1 (de) 1983-12-01
ES8507468A1 (es) 1985-09-01
IL66071A0 (en) 1982-09-30
ES8507469A1 (es) 1985-09-01
ES513388A0 (es) 1984-06-01
EP0081581A4 (en) 1983-11-21
GR76842B (US06515009-20030204-C00004.png) 1984-09-04
ES530208A0 (es) 1985-09-01
NL8220253A (nl) 1983-05-02
ZA824341B (en) 1983-04-27
EP0081581B1 (en) 1986-12-30
ES8405358A1 (es) 1984-06-01
IL66071A (en) 1986-09-30
WO1983000015A1 (en) 1983-01-06
ES530207A0 (es) 1985-09-01

Similar Documents

Publication Publication Date Title
FR2503923B1 (US06515009-20030204-C00004.png)
FR2503188B1 (US06515009-20030204-C00004.png)
FR2501436B1 (US06515009-20030204-C00004.png)
FR2502205B1 (US06515009-20030204-C00004.png)
FR2502113B1 (US06515009-20030204-C00004.png)
FR2499551B1 (US06515009-20030204-C00004.png)
FR2500776B1 (US06515009-20030204-C00004.png)
FR2500243B1 (US06515009-20030204-C00004.png)
FR2502622B1 (US06515009-20030204-C00004.png)
FR2504209B1 (US06515009-20030204-C00004.png)
FR2503875B1 (US06515009-20030204-C00004.png)
FR2501231B1 (US06515009-20030204-C00004.png)
FR2500730B1 (US06515009-20030204-C00004.png)
CH655443B (US06515009-20030204-C00004.png)
FR2498718B3 (US06515009-20030204-C00004.png)
FR2498637B1 (US06515009-20030204-C00004.png)
FR2501242B1 (US06515009-20030204-C00004.png)
FR2501309B1 (US06515009-20030204-C00004.png)
FR2504379B3 (US06515009-20030204-C00004.png)
FR2504009B1 (US06515009-20030204-C00004.png)
FR2504016B1 (US06515009-20030204-C00004.png)
FR2502921B1 (US06515009-20030204-C00004.png)
FR2498597B1 (US06515009-20030204-C00004.png)
FR2500999B1 (US06515009-20030204-C00004.png)
FR2503837B1 (US06515009-20030204-C00004.png)